nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—Appetite Suppression—Phendimetrazine—obesity	0.103	0.184	CiPCiCtD
Sibutramine—Appetite Suppression—Diethylpropion—obesity	0.103	0.184	CiPCiCtD
Sibutramine—Appetite Suppression—Benzphetamine—obesity	0.103	0.184	CiPCiCtD
Sibutramine—Appetite Suppression—Phentermine—obesity	0.103	0.184	CiPCiCtD
Sibutramine—SLC6A4—obesity	0.0907	1	CbGaD
Sibutramine—Appetite Suppression—Methamphetamine—obesity	0.0783	0.14	CiPCiCtD
Sibutramine—Norepinephrine Uptake Inhibitors—Bupropion—obesity	0.0698	0.124	CiPCiCtD
Sibutramine—SLC6A3—Diethylpropion—obesity	0.0305	0.113	CbGbCtD
Sibutramine—SLC6A3—Phendimetrazine—obesity	0.0231	0.086	CbGbCtD
Sibutramine—SLC6A2—Diethylpropion—obesity	0.0223	0.083	CbGbCtD
Sibutramine—SLC6A3—Benzphetamine—obesity	0.0175	0.0652	CbGbCtD
Sibutramine—SLC6A3—Phentermine—obesity	0.0175	0.0652	CbGbCtD
Sibutramine—SLC6A2—Phendimetrazine—obesity	0.0169	0.0629	CbGbCtD
Sibutramine—SLC6A3—Phenylpropanolamine—obesity	0.0167	0.0622	CbGbCtD
Sibutramine—SLC6A4—Phentermine—obesity	0.0153	0.057	CbGbCtD
Sibutramine—SLC6A3—Bupropion—obesity	0.0149	0.0554	CbGbCtD
Sibutramine—SLC6A3—Methamphetamine—obesity	0.014	0.0521	CbGbCtD
Sibutramine—SLC6A2—Phentermine—obesity	0.0128	0.0477	CbGbCtD
Sibutramine—SLC6A2—Benzphetamine—obesity	0.0128	0.0477	CbGbCtD
Sibutramine—SLC6A4—Methamphetamine—obesity	0.0123	0.0456	CbGbCtD
Sibutramine—SLC6A2—Phenylpropanolamine—obesity	0.0122	0.0455	CbGbCtD
Sibutramine—SLC6A2—Bupropion—obesity	0.0109	0.0405	CbGbCtD
Sibutramine—SLC6A2—Methamphetamine—obesity	0.0103	0.0381	CbGbCtD
Sibutramine—CYP3A4—Benzphetamine—obesity	0.00245	0.00909	CbGbCtD
Sibutramine—CYP3A4—Bupropion—obesity	0.00208	0.00773	CbGbCtD
Sibutramine—CYP3A4—Orlistat—obesity	0.0017	0.0063	CbGbCtD
Sibutramine—CYP3A4—Cimetidine—obesity	0.00153	0.00567	CbGbCtD
Sibutramine—SLC6A2—sympathetic nervous system—obesity	0.00136	0.285	CbGeAlD
Sibutramine—CYP3A4—Topiramate—obesity	0.001	0.00371	CbGbCtD
Sibutramine—SLC6A2—autonomic nervous system—obesity	0.000911	0.192	CbGeAlD
Sibutramine—SLC6A3—hindbrain—obesity	0.000476	0.1	CbGeAlD
Sibutramine—SLC6A4—hindbrain—obesity	0.000436	0.0916	CbGeAlD
Sibutramine—SLC6A3—respiratory system—obesity	0.000291	0.0611	CbGeAlD
Sibutramine—SLC6A4—respiratory system—obesity	0.000266	0.056	CbGeAlD
Sibutramine—SLC6A2—respiratory system—obesity	0.000234	0.0493	CbGeAlD
Sibutramine—SLC6A4—digestive system—obesity	0.000169	0.0356	CbGeAlD
Sibutramine—SLC6A2—adrenal gland—obesity	0.000142	0.0299	CbGeAlD
Sibutramine—SLC6A4—endocrine gland—obesity	0.00014	0.0294	CbGeAlD
Sibutramine—SLC6A2—endocrine gland—obesity	0.000123	0.0259	CbGeAlD
Sibutramine—CYP3A4—digestive system—obesity	8.29e-05	0.0174	CbGeAlD
Sibutramine—CYP3A4—endocrine gland—obesity	6.85e-05	0.0144	CbGeAlD
Sibutramine—CYP3A4—liver—obesity	6.18e-05	0.013	CbGeAlD
Sibutramine—Haemoglobin—Bupropion—obesity	4.07e-05	0.000711	CcSEcCtD
Sibutramine—Headache—Diethylpropion—obesity	4.07e-05	0.000711	CcSEcCtD
Sibutramine—Rhinitis—Bupropion—obesity	4.06e-05	0.000709	CcSEcCtD
Sibutramine—Haemorrhage—Bupropion—obesity	4.05e-05	0.000708	CcSEcCtD
Sibutramine—Back pain—Orlistat—obesity	4.04e-05	0.000706	CcSEcCtD
Sibutramine—Hypoaesthesia—Bupropion—obesity	4.03e-05	0.000704	CcSEcCtD
Sibutramine—Libido decreased—Topiramate—obesity	4.02e-05	0.000703	CcSEcCtD
Sibutramine—Pharyngitis—Bupropion—obesity	4.02e-05	0.000702	CcSEcCtD
Sibutramine—Muscle spasms—Orlistat—obesity	4.02e-05	0.000702	CcSEcCtD
Sibutramine—Oedema peripheral—Bupropion—obesity	3.99e-05	0.000697	CcSEcCtD
Sibutramine—Amnesia—Topiramate—obesity	3.97e-05	0.000694	CcSEcCtD
Sibutramine—Increased appetite—Topiramate—obesity	3.97e-05	0.000694	CcSEcCtD
Sibutramine—Vision blurred—Orlistat—obesity	3.94e-05	0.000688	CcSEcCtD
Sibutramine—Vomiting—Cimetidine—obesity	3.93e-05	0.000686	CcSEcCtD
Sibutramine—Thirst—Topiramate—obesity	3.92e-05	0.000685	CcSEcCtD
Sibutramine—Visual impairment—Bupropion—obesity	3.9e-05	0.000682	CcSEcCtD
Sibutramine—Rash—Cimetidine—obesity	3.89e-05	0.00068	CcSEcCtD
Sibutramine—Dermatitis—Cimetidine—obesity	3.89e-05	0.00068	CcSEcCtD
Sibutramine—Ill-defined disorder—Orlistat—obesity	3.88e-05	0.000677	CcSEcCtD
Sibutramine—Headache—Cimetidine—obesity	3.87e-05	0.000676	CcSEcCtD
Sibutramine—Purpura—Topiramate—obesity	3.87e-05	0.000676	CcSEcCtD
Sibutramine—Nausea—Diethylpropion—obesity	3.86e-05	0.000674	CcSEcCtD
Sibutramine—Hypoglycaemia—Topiramate—obesity	3.82e-05	0.000668	CcSEcCtD
Sibutramine—Angioedema—Orlistat—obesity	3.82e-05	0.000667	CcSEcCtD
Sibutramine—Eye disorder—Bupropion—obesity	3.78e-05	0.000661	CcSEcCtD
Sibutramine—Tinnitus—Bupropion—obesity	3.78e-05	0.00066	CcSEcCtD
Sibutramine—Malaise—Orlistat—obesity	3.77e-05	0.000658	CcSEcCtD
Sibutramine—Vertigo—Orlistat—obesity	3.75e-05	0.000656	CcSEcCtD
Sibutramine—Pain in extremity—Topiramate—obesity	3.73e-05	0.000652	CcSEcCtD
Sibutramine—Osteoarthritis—Topiramate—obesity	3.73e-05	0.000652	CcSEcCtD
Sibutramine—Disturbance in sexual arousal—Topiramate—obesity	3.7e-05	0.000646	CcSEcCtD
Sibutramine—Palpitations—Orlistat—obesity	3.69e-05	0.000645	CcSEcCtD
Sibutramine—Angiopathy—Bupropion—obesity	3.67e-05	0.000642	CcSEcCtD
Sibutramine—Migraine—Topiramate—obesity	3.67e-05	0.000641	CcSEcCtD
Sibutramine—Affect lability—Topiramate—obesity	3.67e-05	0.000641	CcSEcCtD
Sibutramine—Nausea—Cimetidine—obesity	3.67e-05	0.000641	CcSEcCtD
Sibutramine—Immune system disorder—Bupropion—obesity	3.66e-05	0.000639	CcSEcCtD
Sibutramine—Cough—Orlistat—obesity	3.65e-05	0.000637	CcSEcCtD
Sibutramine—Psychotic disorder—Topiramate—obesity	3.64e-05	0.000636	CcSEcCtD
Sibutramine—Chills—Bupropion—obesity	3.63e-05	0.000635	CcSEcCtD
Sibutramine—Convulsion—Orlistat—obesity	3.62e-05	0.000633	CcSEcCtD
Sibutramine—Arrhythmia—Bupropion—obesity	3.62e-05	0.000632	CcSEcCtD
Sibutramine—Face oedema—Topiramate—obesity	3.6e-05	0.000629	CcSEcCtD
Sibutramine—Alopecia—Bupropion—obesity	3.58e-05	0.000625	CcSEcCtD
Sibutramine—Chest pain—Orlistat—obesity	3.56e-05	0.000622	CcSEcCtD
Sibutramine—Myalgia—Orlistat—obesity	3.56e-05	0.000622	CcSEcCtD
Sibutramine—Urinary retention—Topiramate—obesity	3.55e-05	0.00062	CcSEcCtD
Sibutramine—Anxiety—Orlistat—obesity	3.55e-05	0.000619	CcSEcCtD
Sibutramine—Mood swings—Topiramate—obesity	3.53e-05	0.000617	CcSEcCtD
Sibutramine—Malnutrition—Bupropion—obesity	3.53e-05	0.000616	CcSEcCtD
Sibutramine—Discomfort—Orlistat—obesity	3.51e-05	0.000614	CcSEcCtD
Sibutramine—Ataxia—Topiramate—obesity	3.51e-05	0.000613	CcSEcCtD
Sibutramine—Blood creatinine increased—Topiramate—obesity	3.49e-05	0.00061	CcSEcCtD
Sibutramine—Dry mouth—Orlistat—obesity	3.48e-05	0.000608	CcSEcCtD
Sibutramine—Flatulence—Bupropion—obesity	3.47e-05	0.000607	CcSEcCtD
Sibutramine—Dehydration—Topiramate—obesity	3.47e-05	0.000606	CcSEcCtD
Sibutramine—Tension—Bupropion—obesity	3.46e-05	0.000604	CcSEcCtD
Sibutramine—Dysgeusia—Bupropion—obesity	3.45e-05	0.000603	CcSEcCtD
Sibutramine—Liver function test abnormal—Topiramate—obesity	3.44e-05	0.000602	CcSEcCtD
Sibutramine—Nervousness—Bupropion—obesity	3.42e-05	0.000598	CcSEcCtD
Sibutramine—Anaphylactic shock—Orlistat—obesity	3.41e-05	0.000596	CcSEcCtD
Sibutramine—Oedema—Orlistat—obesity	3.41e-05	0.000596	CcSEcCtD
Sibutramine—Back pain—Bupropion—obesity	3.41e-05	0.000596	CcSEcCtD
Sibutramine—Orthostatic hypotension—Topiramate—obesity	3.41e-05	0.000595	CcSEcCtD
Sibutramine—Hypokalaemia—Topiramate—obesity	3.39e-05	0.000593	CcSEcCtD
Sibutramine—Muscle spasms—Bupropion—obesity	3.39e-05	0.000592	CcSEcCtD
Sibutramine—Infection—Orlistat—obesity	3.39e-05	0.000592	CcSEcCtD
Sibutramine—Aspartate aminotransferase increased—Topiramate—obesity	3.36e-05	0.000587	CcSEcCtD
Sibutramine—Vision blurred—Bupropion—obesity	3.32e-05	0.00058	CcSEcCtD
Sibutramine—Skin disorder—Orlistat—obesity	3.31e-05	0.000579	CcSEcCtD
Sibutramine—Tremor—Bupropion—obesity	3.3e-05	0.000577	CcSEcCtD
Sibutramine—Gastritis—Topiramate—obesity	3.3e-05	0.000577	CcSEcCtD
Sibutramine—Hyperhidrosis—Orlistat—obesity	3.3e-05	0.000576	CcSEcCtD
Sibutramine—Muscular weakness—Topiramate—obesity	3.29e-05	0.000575	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Topiramate—obesity	3.29e-05	0.000575	CcSEcCtD
Sibutramine—Ill-defined disorder—Bupropion—obesity	3.27e-05	0.000571	CcSEcCtD
Sibutramine—Anaemia—Bupropion—obesity	3.26e-05	0.000569	CcSEcCtD
Sibutramine—Abdominal distension—Topiramate—obesity	3.25e-05	0.000567	CcSEcCtD
Sibutramine—Agitation—Bupropion—obesity	3.24e-05	0.000566	CcSEcCtD
Sibutramine—Asthma—Topiramate—obesity	3.22e-05	0.000563	CcSEcCtD
Sibutramine—Dysphagia—Topiramate—obesity	3.22e-05	0.000563	CcSEcCtD
Sibutramine—Angioedema—Bupropion—obesity	3.22e-05	0.000563	CcSEcCtD
Sibutramine—Eosinophilia—Topiramate—obesity	3.19e-05	0.000558	CcSEcCtD
Sibutramine—Malaise—Bupropion—obesity	3.18e-05	0.000555	CcSEcCtD
Sibutramine—Vertigo—Bupropion—obesity	3.17e-05	0.000553	CcSEcCtD
Sibutramine—Syncope—Bupropion—obesity	3.16e-05	0.000552	CcSEcCtD
Sibutramine—Leukopenia—Bupropion—obesity	3.16e-05	0.000551	CcSEcCtD
Sibutramine—Angina pectoris—Topiramate—obesity	3.14e-05	0.000549	CcSEcCtD
Sibutramine—Palpitations—Bupropion—obesity	3.12e-05	0.000544	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Orlistat—obesity	3.11e-05	0.000543	CcSEcCtD
Sibutramine—Bronchitis—Topiramate—obesity	3.1e-05	0.000542	CcSEcCtD
Sibutramine—Loss of consciousness—Bupropion—obesity	3.1e-05	0.000541	CcSEcCtD
Sibutramine—Insomnia—Orlistat—obesity	3.08e-05	0.000539	CcSEcCtD
Sibutramine—Cough—Bupropion—obesity	3.08e-05	0.000537	CcSEcCtD
Sibutramine—Paraesthesia—Orlistat—obesity	3.06e-05	0.000535	CcSEcCtD
Sibutramine—Convulsion—Bupropion—obesity	3.05e-05	0.000534	CcSEcCtD
Sibutramine—Hypertension—Bupropion—obesity	3.04e-05	0.000532	CcSEcCtD
Sibutramine—Dysuria—Topiramate—obesity	3.01e-05	0.000527	CcSEcCtD
Sibutramine—Dyspepsia—Orlistat—obesity	3e-05	0.000524	CcSEcCtD
Sibutramine—Arthralgia—Bupropion—obesity	3e-05	0.000524	CcSEcCtD
Sibutramine—Chest pain—Bupropion—obesity	3e-05	0.000524	CcSEcCtD
Sibutramine—Myalgia—Bupropion—obesity	3e-05	0.000524	CcSEcCtD
Sibutramine—Anxiety—Bupropion—obesity	2.99e-05	0.000523	CcSEcCtD
Sibutramine—Pollakiuria—Topiramate—obesity	2.98e-05	0.00052	CcSEcCtD
Sibutramine—Erectile dysfunction—Topiramate—obesity	2.97e-05	0.000519	CcSEcCtD
Sibutramine—Discomfort—Bupropion—obesity	2.97e-05	0.000518	CcSEcCtD
Sibutramine—Decreased appetite—Orlistat—obesity	2.96e-05	0.000518	CcSEcCtD
Sibutramine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	2.96e-05	0.00174	CbGpPWpGaD
Sibutramine—Gastrointestinal disorder—Orlistat—obesity	2.94e-05	0.000514	CcSEcCtD
Sibutramine—Photosensitivity reaction—Topiramate—obesity	2.94e-05	0.000514	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—NQO1—obesity	2.94e-05	0.00173	CbGpPWpGaD
Sibutramine—Dry mouth—Bupropion—obesity	2.94e-05	0.000513	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—BDNF—obesity	2.94e-05	0.00173	CbGpPWpGaD
Sibutramine—Weight increased—Topiramate—obesity	2.93e-05	0.000513	CcSEcCtD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	2.92e-05	0.00172	CbGpPWpGaD
Sibutramine—Pain—Orlistat—obesity	2.92e-05	0.00051	CcSEcCtD
Sibutramine—Hyperglycaemia—Topiramate—obesity	2.91e-05	0.000508	CcSEcCtD
Sibutramine—Confusional state—Bupropion—obesity	2.9e-05	0.000507	CcSEcCtD
Sibutramine—Pneumonia—Topiramate—obesity	2.89e-05	0.000505	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—DRD2—obesity	2.89e-05	0.0017	CbGpPWpGaD
Sibutramine—SLC6A3—Monoamine Transport—TNF—obesity	2.88e-05	0.0017	CbGpPWpGaD
Sibutramine—Anaphylactic shock—Bupropion—obesity	2.88e-05	0.000503	CcSEcCtD
Sibutramine—Oedema—Bupropion—obesity	2.88e-05	0.000503	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GABRA6—obesity	2.87e-05	0.00169	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—FTL—obesity	2.87e-05	0.00169	CbGpPWpGaD
Sibutramine—Depression—Topiramate—obesity	2.87e-05	0.000501	CcSEcCtD
Sibutramine—Infection—Bupropion—obesity	2.86e-05	0.000499	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—KCNMA1—obesity	2.85e-05	0.00168	CbGpPWpGaD
Sibutramine—Shock—Bupropion—obesity	2.83e-05	0.000495	CcSEcCtD
Sibutramine—Renal failure—Topiramate—obesity	2.83e-05	0.000494	CcSEcCtD
Sibutramine—Neuropathy peripheral—Topiramate—obesity	2.82e-05	0.000492	CcSEcCtD
Sibutramine—Thrombocytopenia—Bupropion—obesity	2.82e-05	0.000492	CcSEcCtD
Sibutramine—SLC6A3—NRF2 pathway—SLC2A4—obesity	2.82e-05	0.00166	CbGpPWpGaD
Sibutramine—Feeling abnormal—Orlistat—obesity	2.81e-05	0.000491	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—COX7C—obesity	2.81e-05	0.00165	CbGpPWpGaD
Sibutramine—Tachycardia—Bupropion—obesity	2.81e-05	0.000491	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL10—obesity	2.8e-05	0.00165	CbGpPWpGaD
Sibutramine—Stomatitis—Topiramate—obesity	2.8e-05	0.000489	CcSEcCtD
Sibutramine—Skin disorder—Bupropion—obesity	2.79e-05	0.000488	CcSEcCtD
Sibutramine—Conjunctivitis—Topiramate—obesity	2.79e-05	0.000488	CcSEcCtD
Sibutramine—Urinary tract infection—Topiramate—obesity	2.79e-05	0.000488	CcSEcCtD
Sibutramine—Gastrointestinal pain—Orlistat—obesity	2.79e-05	0.000487	CcSEcCtD
Sibutramine—Hyperhidrosis—Bupropion—obesity	2.78e-05	0.000486	CcSEcCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	2.77e-05	0.00163	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC6A14—obesity	2.75e-05	0.00162	CbGpPWpGaD
Sibutramine—Anorexia—Bupropion—obesity	2.74e-05	0.000479	CcSEcCtD
Sibutramine—Haematuria—Topiramate—obesity	2.74e-05	0.000479	CcSEcCtD
Sibutramine—SLC6A2—NRF2 pathway—HMOX1—obesity	2.73e-05	0.00161	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—GGT1—obesity	2.73e-05	0.00161	CbGpPWpGaD
Sibutramine—Epistaxis—Topiramate—obesity	2.71e-05	0.000474	CcSEcCtD
Sibutramine—Urticaria—Orlistat—obesity	2.71e-05	0.000473	CcSEcCtD
Sibutramine—Sinusitis—Topiramate—obesity	2.7e-05	0.000471	CcSEcCtD
Sibutramine—Abdominal pain—Orlistat—obesity	2.7e-05	0.000471	CcSEcCtD
Sibutramine—Body temperature increased—Orlistat—obesity	2.7e-05	0.000471	CcSEcCtD
Sibutramine—Hypotension—Bupropion—obesity	2.69e-05	0.00047	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	2.67e-05	0.00157	CbGpPWpGaD
Sibutramine—Bradycardia—Topiramate—obesity	2.63e-05	0.000459	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—obesity	2.63e-05	0.00155	CbGpPWpGaD
Sibutramine—Musculoskeletal discomfort—Bupropion—obesity	2.62e-05	0.000458	CcSEcCtD
Sibutramine—Insomnia—Bupropion—obesity	2.6e-05	0.000455	CcSEcCtD
Sibutramine—Haemoglobin—Topiramate—obesity	2.59e-05	0.000453	CcSEcCtD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—obesity	2.59e-05	0.00153	CbGpPWpGaD
Sibutramine—Rhinitis—Topiramate—obesity	2.59e-05	0.000452	CcSEcCtD
Sibutramine—Paraesthesia—Bupropion—obesity	2.58e-05	0.000451	CcSEcCtD
Sibutramine—Haemorrhage—Topiramate—obesity	2.58e-05	0.000451	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—GCK—obesity	2.58e-05	0.00152	CbGpPWpGaD
Sibutramine—Hypoaesthesia—Topiramate—obesity	2.57e-05	0.000449	CcSEcCtD
Sibutramine—Dyspnoea—Bupropion—obesity	2.57e-05	0.000448	CcSEcCtD
Sibutramine—Pharyngitis—Topiramate—obesity	2.56e-05	0.000447	CcSEcCtD
Sibutramine—Somnolence—Bupropion—obesity	2.56e-05	0.000447	CcSEcCtD
Sibutramine—Oedema peripheral—Topiramate—obesity	2.54e-05	0.000444	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—FTL—obesity	2.54e-05	0.0015	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GABRA6—obesity	2.54e-05	0.0015	CbGpPWpGaD
Sibutramine—Dyspepsia—Bupropion—obesity	2.53e-05	0.000443	CcSEcCtD
Sibutramine—Hypersensitivity—Orlistat—obesity	2.51e-05	0.000439	CcSEcCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	2.5e-05	0.00147	CbGpPWpGaD
Sibutramine—Decreased appetite—Bupropion—obesity	2.5e-05	0.000437	CcSEcCtD
Sibutramine—Visual impairment—Topiramate—obesity	2.49e-05	0.000434	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Bupropion—obesity	2.48e-05	0.000434	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—SLC22A1—obesity	2.48e-05	0.00146	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—obesity	2.48e-05	0.00146	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARGC1A—obesity	2.47e-05	0.00145	CbGpPWpGaD
Sibutramine—Pain—Bupropion—obesity	2.46e-05	0.00043	CcSEcCtD
Sibutramine—Constipation—Bupropion—obesity	2.46e-05	0.00043	CcSEcCtD
Sibutramine—Asthenia—Orlistat—obesity	2.45e-05	0.000427	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC6A14—obesity	2.44e-05	0.00143	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—HMOX1—obesity	2.42e-05	0.00142	CbGpPWpGaD
Sibutramine—Pruritus—Orlistat—obesity	2.41e-05	0.000422	CcSEcCtD
Sibutramine—Eye disorder—Topiramate—obesity	2.41e-05	0.000421	CcSEcCtD
Sibutramine—Tinnitus—Topiramate—obesity	2.41e-05	0.00042	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—BCHE—obesity	2.39e-05	0.00141	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—SIRT1—obesity	2.39e-05	0.00141	CbGpPWpGaD
Sibutramine—Feeling abnormal—Bupropion—obesity	2.37e-05	0.000414	CcSEcCtD
Sibutramine—Gastrointestinal pain—Bupropion—obesity	2.35e-05	0.000411	CcSEcCtD
Sibutramine—Angiopathy—Topiramate—obesity	2.34e-05	0.000409	CcSEcCtD
Sibutramine—Diarrhoea—Orlistat—obesity	2.33e-05	0.000408	CcSEcCtD
Sibutramine—Immune system disorder—Topiramate—obesity	2.33e-05	0.000407	CcSEcCtD
Sibutramine—Chills—Topiramate—obesity	2.32e-05	0.000404	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	2.29e-05	0.00135	CbGpPWpGaD
Sibutramine—Urticaria—Bupropion—obesity	2.29e-05	0.000399	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—GCK—obesity	2.28e-05	0.00134	CbGpPWpGaD
Sibutramine—Alopecia—Topiramate—obesity	2.28e-05	0.000398	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC9A3—obesity	2.28e-05	0.00134	CbGpPWpGaD
Sibutramine—Abdominal pain—Bupropion—obesity	2.27e-05	0.000397	CcSEcCtD
Sibutramine—Body temperature increased—Bupropion—obesity	2.27e-05	0.000397	CcSEcCtD
Sibutramine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	2.26e-05	0.00133	CbGpPWpGaD
Sibutramine—Dizziness—Orlistat—obesity	2.26e-05	0.000394	CcSEcCtD
Sibutramine—Malnutrition—Topiramate—obesity	2.25e-05	0.000392	CcSEcCtD
Sibutramine—Flatulence—Topiramate—obesity	2.21e-05	0.000387	CcSEcCtD
Sibutramine—Tension—Topiramate—obesity	2.2e-05	0.000385	CcSEcCtD
Sibutramine—Dysgeusia—Topiramate—obesity	2.2e-05	0.000384	CcSEcCtD
Sibutramine—Nervousness—Topiramate—obesity	2.18e-05	0.000381	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HK2—obesity	2.17e-05	0.00128	CbGpPWpGaD
Sibutramine—Back pain—Topiramate—obesity	2.17e-05	0.00038	CcSEcCtD
Sibutramine—Vomiting—Orlistat—obesity	2.17e-05	0.000379	CcSEcCtD
Sibutramine—Muscle spasms—Topiramate—obesity	2.16e-05	0.000377	CcSEcCtD
Sibutramine—Rash—Orlistat—obesity	2.15e-05	0.000376	CcSEcCtD
Sibutramine—Dermatitis—Orlistat—obesity	2.15e-05	0.000375	CcSEcCtD
Sibutramine—Headache—Orlistat—obesity	2.14e-05	0.000373	CcSEcCtD
Sibutramine—Hypersensitivity—Bupropion—obesity	2.12e-05	0.00037	CcSEcCtD
Sibutramine—Vision blurred—Topiramate—obesity	2.12e-05	0.00037	CcSEcCtD
Sibutramine—Tremor—Topiramate—obesity	2.1e-05	0.000368	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC27A1—obesity	2.08e-05	0.00123	CbGpPWpGaD
Sibutramine—Ill-defined disorder—Topiramate—obesity	2.08e-05	0.000364	CcSEcCtD
Sibutramine—Anaemia—Topiramate—obesity	2.08e-05	0.000363	CcSEcCtD
Sibutramine—Asthenia—Bupropion—obesity	2.06e-05	0.000361	CcSEcCtD
Sibutramine—Agitation—Topiramate—obesity	2.06e-05	0.000361	CcSEcCtD
Sibutramine—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	2.04e-05	0.0012	CbGpPWpGaD
Sibutramine—Pruritus—Bupropion—obesity	2.04e-05	0.000356	CcSEcCtD
Sibutramine—Nausea—Orlistat—obesity	2.03e-05	0.000354	CcSEcCtD
Sibutramine—Malaise—Topiramate—obesity	2.03e-05	0.000354	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC9A3—obesity	2.02e-05	0.00119	CbGpPWpGaD
Sibutramine—Vertigo—Topiramate—obesity	2.02e-05	0.000353	CcSEcCtD
Sibutramine—Syncope—Topiramate—obesity	2.01e-05	0.000352	CcSEcCtD
Sibutramine—Leukopenia—Topiramate—obesity	2.01e-05	0.000351	CcSEcCtD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—obesity	2e-05	0.00118	CbGpPWpGaD
Sibutramine—Palpitations—Topiramate—obesity	1.98e-05	0.000347	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARA—obesity	1.98e-05	0.00117	CbGpPWpGaD
Sibutramine—Loss of consciousness—Topiramate—obesity	1.97e-05	0.000345	CcSEcCtD
Sibutramine—Diarrhoea—Bupropion—obesity	1.97e-05	0.000344	CcSEcCtD
Sibutramine—Cough—Topiramate—obesity	1.96e-05	0.000342	CcSEcCtD
Sibutramine—Convulsion—Topiramate—obesity	1.95e-05	0.00034	CcSEcCtD
Sibutramine—Hypertension—Topiramate—obesity	1.94e-05	0.000339	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HK2—obesity	1.93e-05	0.00113	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	1.92e-05	0.00113	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—COMT—obesity	1.91e-05	0.00113	CbGpPWpGaD
Sibutramine—Arthralgia—Topiramate—obesity	1.91e-05	0.000334	CcSEcCtD
Sibutramine—Chest pain—Topiramate—obesity	1.91e-05	0.000334	CcSEcCtD
Sibutramine—Myalgia—Topiramate—obesity	1.91e-05	0.000334	CcSEcCtD
Sibutramine—Anxiety—Topiramate—obesity	1.91e-05	0.000333	CcSEcCtD
Sibutramine—Dizziness—Bupropion—obesity	1.9e-05	0.000332	CcSEcCtD
Sibutramine—Discomfort—Topiramate—obesity	1.89e-05	0.00033	CcSEcCtD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—GNB3—obesity	1.89e-05	0.00111	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—LEP—obesity	1.88e-05	0.00111	CbGpPWpGaD
Sibutramine—Dry mouth—Topiramate—obesity	1.87e-05	0.000327	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	1.85e-05	0.00109	CbGpPWpGaD
Sibutramine—Confusional state—Topiramate—obesity	1.85e-05	0.000323	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC27A1—obesity	1.85e-05	0.00109	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—BCHE—obesity	1.83e-05	0.00108	CbGpPWpGaD
Sibutramine—Oedema—Topiramate—obesity	1.83e-05	0.00032	CcSEcCtD
Sibutramine—Vomiting—Bupropion—obesity	1.83e-05	0.00032	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	1.83e-05	0.00108	CbGpPWpGaD
Sibutramine—Infection—Topiramate—obesity	1.82e-05	0.000318	CcSEcCtD
Sibutramine—Rash—Bupropion—obesity	1.81e-05	0.000317	CcSEcCtD
Sibutramine—Dermatitis—Bupropion—obesity	1.81e-05	0.000317	CcSEcCtD
Sibutramine—Shock—Topiramate—obesity	1.8e-05	0.000315	CcSEcCtD
Sibutramine—Headache—Bupropion—obesity	1.8e-05	0.000315	CcSEcCtD
Sibutramine—Thrombocytopenia—Topiramate—obesity	1.79e-05	0.000314	CcSEcCtD
Sibutramine—Tachycardia—Topiramate—obesity	1.79e-05	0.000313	CcSEcCtD
Sibutramine—Skin disorder—Topiramate—obesity	1.78e-05	0.000311	CcSEcCtD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—obesity	1.77e-05	0.00105	CbGpPWpGaD
Sibutramine—Hyperhidrosis—Topiramate—obesity	1.77e-05	0.00031	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TRPV1—obesity	1.77e-05	0.00104	CbGpPWpGaD
Sibutramine—Anorexia—Topiramate—obesity	1.75e-05	0.000305	CcSEcCtD
Sibutramine—Hypotension—Topiramate—obesity	1.71e-05	0.000299	CcSEcCtD
Sibutramine—Nausea—Bupropion—obesity	1.71e-05	0.000299	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HK1—obesity	1.71e-05	0.001	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	1.68e-05	0.000987	CbGpPWpGaD
Sibutramine—Musculoskeletal discomfort—Topiramate—obesity	1.67e-05	0.000292	CcSEcCtD
Sibutramine—Insomnia—Topiramate—obesity	1.66e-05	0.00029	CcSEcCtD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	1.65e-05	0.000973	CbGpPWpGaD
Sibutramine—Paraesthesia—Topiramate—obesity	1.65e-05	0.000288	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—PPARG—obesity	1.64e-05	0.000966	CbGpPWpGaD
Sibutramine—Dyspnoea—Topiramate—obesity	1.63e-05	0.000286	CcSEcCtD
Sibutramine—Somnolence—Topiramate—obesity	1.63e-05	0.000285	CcSEcCtD
Sibutramine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	1.63e-05	0.00096	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP26B1—obesity	1.62e-05	0.000951	CbGpPWpGaD
Sibutramine—Dyspepsia—Topiramate—obesity	1.61e-05	0.000282	CcSEcCtD
Sibutramine—Decreased appetite—Topiramate—obesity	1.59e-05	0.000278	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	1.59e-05	0.000938	CbGpPWpGaD
Sibutramine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	1.58e-05	0.000933	CbGpPWpGaD
Sibutramine—Gastrointestinal disorder—Topiramate—obesity	1.58e-05	0.000277	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TRPV1—obesity	1.57e-05	0.000925	CbGpPWpGaD
Sibutramine—Constipation—Topiramate—obesity	1.57e-05	0.000274	CcSEcCtD
Sibutramine—Pain—Topiramate—obesity	1.57e-05	0.000274	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HK1—obesity	1.51e-05	0.00089	CbGpPWpGaD
Sibutramine—Feeling abnormal—Topiramate—obesity	1.51e-05	0.000264	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC22A1—obesity	1.51e-05	0.000887	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	1.5e-05	0.000885	CbGpPWpGaD
Sibutramine—Gastrointestinal pain—Topiramate—obesity	1.5e-05	0.000262	CcSEcCtD
Sibutramine—SLC6A4—Circadian rythm related genes—SERPINE1—obesity	1.48e-05	0.00087	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL1B—obesity	1.47e-05	0.000866	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—COMT—obesity	1.47e-05	0.000863	CbGpPWpGaD
Sibutramine—Urticaria—Topiramate—obesity	1.46e-05	0.000254	CcSEcCtD
Sibutramine—Body temperature increased—Topiramate—obesity	1.45e-05	0.000253	CcSEcCtD
Sibutramine—Abdominal pain—Topiramate—obesity	1.45e-05	0.000253	CcSEcCtD
Sibutramine—SLC6A3—Neuronal System—GNB3—obesity	1.45e-05	0.000851	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—ADH1B—obesity	1.42e-05	0.000834	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PRKAR2B—obesity	1.39e-05	0.000819	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	1.36e-05	0.0008	CbGpPWpGaD
Sibutramine—SLC6A3—Transmission across Chemical Synapses—PRKCB—obesity	1.36e-05	0.0008	CbGpPWpGaD
Sibutramine—Hypersensitivity—Topiramate—obesity	1.35e-05	0.000236	CcSEcCtD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	1.34e-05	0.000788	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC22A1—obesity	1.33e-05	0.000786	CbGpPWpGaD
Sibutramine—Asthenia—Topiramate—obesity	1.32e-05	0.00023	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GCK—obesity	1.31e-05	0.000771	CbGpPWpGaD
Sibutramine—Pruritus—Topiramate—obesity	1.3e-05	0.000227	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CETP—obesity	1.26e-05	0.000744	CbGpPWpGaD
Sibutramine—Diarrhoea—Topiramate—obesity	1.25e-05	0.000219	CcSEcCtD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TF—obesity	1.25e-05	0.000735	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PRKAR2B—obesity	1.23e-05	0.000726	CbGpPWpGaD
Sibutramine—Dizziness—Topiramate—obesity	1.21e-05	0.000212	CcSEcCtD
Sibutramine—SLC6A4—NRF2 pathway—TGFB1—obesity	1.2e-05	0.000709	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—TFRC—obesity	1.2e-05	0.000705	CbGpPWpGaD
Sibutramine—Vomiting—Topiramate—obesity	1.17e-05	0.000204	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GCK—obesity	1.16e-05	0.000683	CbGpPWpGaD
Sibutramine—Rash—Topiramate—obesity	1.16e-05	0.000202	CcSEcCtD
Sibutramine—Dermatitis—Topiramate—obesity	1.15e-05	0.000202	CcSEcCtD
Sibutramine—Headache—Topiramate—obesity	1.15e-05	0.000201	CcSEcCtD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CETP—obesity	1.12e-05	0.000659	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TF—obesity	1.11e-05	0.000651	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—MAPK8—obesity	1.1e-05	0.000648	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—SULT2A1—obesity	1.09e-05	0.000643	CbGpPWpGaD
Sibutramine—Nausea—Topiramate—obesity	1.09e-05	0.00019	CcSEcCtD
Sibutramine—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	1.08e-05	0.000634	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—TNF—obesity	1.07e-05	0.000628	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—TFRC—obesity	1.06e-05	0.000625	CbGpPWpGaD
Sibutramine—SLC6A3—Neuronal System—PRKCB—obesity	1.04e-05	0.000613	CbGpPWpGaD
Sibutramine—SLC6A2—NRF2 pathway—TGFB1—obesity	1.04e-05	0.00061	CbGpPWpGaD
Sibutramine—SLC6A2—SLC-mediated transmembrane transport—ALB—obesity	1.03e-05	0.000608	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—GPX3—obesity	1.03e-05	0.000605	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—obesity	1.02e-05	0.000599	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—CYCS—obesity	1e-05	0.000592	CbGpPWpGaD
Sibutramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	9.92e-06	0.000584	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—NCOA1—obesity	9.71e-06	0.000572	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PLG—obesity	9.46e-06	0.000557	CbGpPWpGaD
Sibutramine—SLC6A3—NRF2 pathway—TGFB1—obesity	9.17e-06	0.00054	CbGpPWpGaD
Sibutramine—SLC6A3—SLC-mediated transmembrane transport—ALB—obesity	9.14e-06	0.000538	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—obesity	9.02e-06	0.000531	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	9e-06	0.00053	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—CYCS—obesity	8.9e-06	0.000524	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GNB3—obesity	8.77e-06	0.000517	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—HMOX1—obesity	8.73e-06	0.000514	CbGpPWpGaD
Sibutramine—SLC6A4—SIDS Susceptibility Pathways—IL6—obesity	8.61e-06	0.000507	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—NCOA1—obesity	8.6e-06	0.000507	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—GNAS—obesity	8.54e-06	0.000503	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PLG—obesity	8.38e-06	0.000494	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOB—obesity	8.36e-06	0.000493	CbGpPWpGaD
Sibutramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	8.04e-06	0.000474	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP2E1—obesity	7.98e-06	0.00047	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	7.87e-06	0.000463	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GNB3—obesity	7.77e-06	0.000458	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—HMOX1—obesity	7.74e-06	0.000456	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—GNAS—obesity	7.57e-06	0.000446	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOB—obesity	7.41e-06	0.000436	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—GGT1—obesity	7.32e-06	0.000431	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—NCOA1—obesity	7.21e-06	0.000425	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—CYP19A1—obesity	7.11e-06	0.000419	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—PPARA—obesity	7.05e-06	0.000416	CbGpPWpGaD
Sibutramine—SLC6A4—Circadian rythm related genes—IL6—obesity	7.03e-06	0.000414	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	7.01e-06	0.000413	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CA3—obesity	6.65e-06	0.000392	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—APOA1—obesity	6.62e-06	0.00039	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—COMT—obesity	6.61e-06	0.000389	CbGpPWpGaD
Sibutramine—CYP3A4—Metapathway biotransformation—COMT—obesity	6.52e-06	0.000384	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—PPARA—obesity	6.25e-06	0.000368	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—APOA1—obesity	5.86e-06	0.000345	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GLRX—obesity	5.66e-06	0.000333	CbGpPWpGaD
Sibutramine—SLC6A2—Transmembrane transport of small molecules—ALB—obesity	5.24e-06	0.000309	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INSIG2—obesity	5.04e-06	0.000297	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ETFDH—obesity	5.04e-06	0.000297	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPM1L—obesity	5.04e-06	0.000297	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—OTC—obesity	5.04e-06	0.000297	CbGpPWpGaD
Sibutramine—SLC6A3—Transmembrane transport of small molecules—ALB—obesity	4.64e-06	0.000274	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPT—obesity	4.61e-06	0.000272	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INPP5E—obesity	4.61e-06	0.000272	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UQCRC2—obesity	4.61e-06	0.000272	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SUCLG2—obesity	4.29e-06	0.000252	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ME1—obesity	4.29e-06	0.000252	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALDH6A1—obesity	4.29e-06	0.000252	CbGpPWpGaD
Sibutramine—CYP3A4—Biological oxidations—POMC—obesity	4.27e-06	0.000252	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UCP1—obesity	4.03e-06	0.000237	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PNPLA3—obesity	4.03e-06	0.000237	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COX7C—obesity	4.03e-06	0.000237	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CS—obesity	3.82e-06	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DGAT2—obesity	3.82e-06	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SUCLA2—obesity	3.82e-06	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CPS1—obesity	3.82e-06	0.000225	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MUT—obesity	3.64e-06	0.000215	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LIPE—obesity	3.64e-06	0.000215	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYB5A—obesity	3.49e-06	0.000206	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DGAT1—obesity	3.49e-06	0.000206	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACLY—obesity	3.36e-06	0.000198	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALOX12—obesity	3.25e-06	0.000191	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ENPP1—obesity	3.25e-06	0.000191	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMGCS1—obesity	3.15e-06	0.000185	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACADM—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PLIN1—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PFKFB3—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ANGPTL4—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SAT1—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PNPLA2—obesity	3.05e-06	0.00018	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—OXCT1—obesity	2.97e-06	0.000175	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACACB—obesity	2.97e-06	0.000175	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYTB—obesity	2.97e-06	0.000175	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PNLIP—obesity	2.9e-06	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SRD5A1—obesity	2.9e-06	0.000171	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SDC3—obesity	2.83e-06	0.000166	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—STS—obesity	2.76e-06	0.000163	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HK2—obesity	2.76e-06	0.000163	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP26B1—obesity	2.76e-06	0.000163	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARD—obesity	2.7e-06	0.000159	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC27A1—obesity	2.65e-06	0.000156	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FABP4—obesity	2.6e-06	0.000153	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GLUL—obesity	2.6e-06	0.000153	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UCP3—obesity	2.46e-06	0.000145	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—UCP2—obesity	2.46e-06	0.000145	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ECHS1—obesity	2.46e-06	0.000145	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HSD11B1—obesity	2.46e-06	0.000145	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ADH1B—obesity	2.42e-06	0.000143	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARGC1B—obesity	2.38e-06	0.00014	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACSL1—obesity	2.38e-06	0.00014	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPAM—obesity	2.38e-06	0.00014	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PCK1—obesity	2.31e-06	0.000136	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HADH—obesity	2.31e-06	0.000136	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FADS1—obesity	2.31e-06	0.000136	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ACP5—obesity	2.25e-06	0.000133	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—G6PD—obesity	2.19e-06	0.000129	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HK1—obesity	2.17e-06	0.000128	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SREBF2—obesity	2.17e-06	0.000128	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPA—obesity	2.09e-06	0.000123	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPIN1—obesity	2.05e-06	0.000121	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA5—obesity	2.01e-06	0.000118	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CLOCK—obesity	1.91e-06	0.000113	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC22A1—obesity	1.91e-06	0.000113	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SULT2A1—obesity	1.87e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GLP1R—obesity	1.87e-06	0.00011	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DPYD—obesity	1.84e-06	0.000108	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PRKAR2B—obesity	1.77e-06	0.000104	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—DCN—obesity	1.75e-06	0.000103	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CPT1A—obesity	1.71e-06	0.000101	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NAMPT—obesity	1.67e-06	9.86e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LIPC—obesity	1.66e-06	9.8e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCK—obesity	1.66e-06	9.8e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOC3—obesity	1.65e-06	9.73e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CETP—obesity	1.6e-06	9.45e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SDC1—obesity	1.59e-06	9.34e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKR1C3—obesity	1.56e-06	9.19e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SCARB1—obesity	1.54e-06	9.05e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SREBF1—obesity	1.49e-06	8.79e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT2—obesity	1.45e-06	8.55e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—FASN—obesity	1.42e-06	8.36e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—BCHE—obesity	1.41e-06	8.33e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP2E1—obesity	1.36e-06	8.04e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NQO1—obesity	1.35e-06	7.95e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GCG—obesity	1.29e-06	7.62e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—SLC2A4—obesity	1.29e-06	7.62e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYCS—obesity	1.28e-06	7.52e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GOT1—obesity	1.25e-06	7.38e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GGT1—obesity	1.25e-06	7.38e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NCOA1—obesity	1.23e-06	7.27e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—STK11—obesity	1.22e-06	7.16e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CYP19A1—obesity	1.22e-06	7.16e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—COMT—obesity	1.13e-06	6.66e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GNB3—obesity	1.11e-06	6.57e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARGC1A—obesity	1.11e-06	6.57e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—HMOX1—obesity	1.11e-06	6.54e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GNAS—obesity	1.09e-06	6.39e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOB—obesity	1.06e-06	6.26e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—LPL—obesity	1.01e-06	5.98e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—GPX1—obesity	9.9e-07	5.83e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CD36—obesity	9.64e-07	5.68e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—MTHFR—obesity	9.14e-07	5.38e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARA—obesity	8.96e-07	5.28e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AGT—obesity	8.68e-07	5.11e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOE—obesity	8.51e-07	5.01e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—CAV1—obesity	8.43e-07	4.96e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—APOA1—obesity	8.41e-07	4.95e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CG—obesity	7.68e-07	4.52e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PPARG—obesity	7.41e-07	4.36e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—POMC—obesity	7.31e-07	4.3e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—INS—obesity	7.27e-07	4.28e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CD—obesity	6.75e-07	3.98e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—ALB—obesity	6.66e-07	3.92e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—NOS3—obesity	6.37e-07	3.75e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3R1—obesity	6.37e-07	3.75e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CB—obesity	5.88e-07	3.46e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PTGS2—obesity	5.83e-07	3.43e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—PIK3CA—obesity	3.59e-07	2.11e-05	CbGpPWpGaD
Sibutramine—CYP3A4—Metabolism—AKT1—obesity	2.93e-07	1.73e-05	CbGpPWpGaD
